Chart of the Week: Liquid Biopsy Focused on Lung Cancer

Last week we did a follow-up webinar on liquid biopsy.  In the extended analysis it became apparent that lung cancer is the focus of liquid biopsy. While breast cancer shows up on the top of this list, the combination of NSCLC and lung cancer surpasses breast cancer...

Chart of the Week: Can Liquid Biopsy Screen for Disease?

We believe that the holy grail of liquid biopsy is screening capability in urine samples. In preparation for our liquid biopsy webinar at the end of this month we’ve been analyzing information on the state of liquid biopsy. For some of the up-and-comer liquid...

Companion Diagnostics Play a Confusing Role with PD-1 Inhibitors

  There are now three approved drugs that target PD-1 either directly or indirectly, and more are under development.While these drugs all seek to inhibit PD-1’s immune suppressive activity, they are quite different in the ways that companion diagnostic tests play...

Metabolic Biomarkers Dominate Companion Diagnostics

We are soon going to release a report describing trends in the development and use of companion diagnostic biomarkers, and a key part of preparing this report was breaking down companion diagnostic biomarkers into relevant groups.  A very clear initial division is...